Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06947538 · ClinicalTrials.gov registry record · NA
Stepped Care for Posttraumatic Stress Disorder Study
A NA study of Post Traumatic Stress Disorder, sponsored by Boston Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 428
- Enrollment target
- 1
- Study location
NCT06947538: Recruiting NA study of Post Traumatic Stress Disorder, sponsored by Boston Medical Center.
NCT06947538 is a NA study of Post Traumatic Stress Disorder that is actively recruiting participants, run by Boston Medical Center. The registered enrollment target is 428 participants, below the 662-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (35% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06947538, a NA study of Post Traumatic Stress Disorder, is actively recruiting participants, sponsored by Boston Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 428 participants
- Enrollment target
- 1
- Study location
Study Summary
Less than 20% of people with PTSD receive any treatment. This study extends a program of research by the investigator focused on developing adaptive (stepped) interventions for PTSD. The adaptive intervention sequences a digital mental health intervention (DMHI) and brief trauma- and skills-focused treatments for PTSD. The selected treatments are brief and scalable and less burdensome to systems of care. These treatments are: web-administered Skills Training in Affective and Interpersonal Regulation (webSTAIR), Brief STAIR, and Written Exposure Therapy (WET).
Primary Outcome
This outcome will be assessed by the PTSD Checklist for the DSM-5 (PCL-5), a 20-item self-report measure that evaluates the degree to which individuals have been bothered by PTSD symptoms in the past month tied to their most distressing event. Total scores ranging from 0 to 80, and a score of 31-33 or higher suggests probable PTSD and potential benefit from treatment.
Conditions Studied
Interventions
- BEHAVIORAL webSTAIR
- BEHAVIORAL WebSTAIR plus coaching
- BEHAVIORAL Clinician administered Brief STAIR
- BEHAVIORAL Clinician administered WET
Study Locations (1)
Massachusetts
- Boston Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 428 participants |
| Start Date | 2026-03-12 |
| Est. Completion | 2029-06 |
| Phase | NA |
What NCT06947538 shows while recruiting
NCT06947538 is an interventional study that assigns participants to a tested intervention. The registered 428 participants enrollment target is mid-sized for trials with a published cap, below the 662-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (35% lower).
The record links to 1 condition, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 4 interventions - of which webSTAIR is the first listed.
NCT06947538 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06947538 about?
NCT06947538 is a clinical study titled "Stepped Care for Posttraumatic Stress Disorder Study". Less than 20% of people with PTSD receive any treatment. This study extends a program of research by the investigator focused on developing adaptive (stepped) interventions for PTSD. The adaptive intervention sequences a digital mental health intervention (DMHI) and brief trauma- and skills-focused ...
What is the current status of trial NCT06947538?
This trial is currently recruiting. It is a NA study. The enrollment target is 428 participants. The study started on 2026-03-12. Estimated completion is 2029-06.
What conditions does trial NCT06947538 study?
This clinical trial studies the following conditions: Post Traumatic Stress Disorder.
What interventions are being tested in trial NCT06947538?
The interventions under investigation include: webSTAIR (BEHAVIORAL), WebSTAIR plus coaching (BEHAVIORAL), Clinician administered Brief STAIR (BEHAVIORAL), Clinician administered WET (BEHAVIORAL).
Who is sponsoring clinical trial NCT06947538?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06947538 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post Traumatic Stress Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06947538's enrollment target sits among peer trials
428 15th of 262 higher than 248 of 262 other Post Traumatic Stress Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Post Traumatic Stress Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
CRISOL Mente: A Multilevel Community Intervention to Reduce Mental Health Disparities Among Latinos
RECRUITING · NA
-
TMS-fNIRS Personalized Dosing
RECRUITING · NA
-
Targeting the Default Mode Network: A TMS-fMRI Study
RECRUITING · NA
-
The Effects of Very Brief Exposure on PTSD in U.S. Combat Veterans
RECRUITING · NA
-
Fear and Avoidance in PTSD Patients
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05566431 · 428 participants · NA
Benchmark Evidence Led by Latin America: Trial of Intracranial Pressure - Pediatrics
- NCT05646316 · 428 participants · Phase 3
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
- NCT05797610 · 428 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression
- NCT06073626 · 428 participants · NA
Addressing Genomic Disparities in Cancer Survivors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI